WallStSmart

Airsculpt Technologies Inc (AIRS)vsUniversal Health Services Inc (UHS)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Universal Health Services Inc generates 10922% more annual revenue ($17.36B vs $157.55M). UHS leads profitability with a 8.6% profit margin vs -11.4%. UHS earns a higher WallStSmart Score of 76/100 (B+).

AIRS

Hold

40

out of 100

Grade: F

Growth: 4.7Profit: 2.0Value: 5.0Quality: 4.0
Piotroski: 1/9Altman Z: 0.94

UHS

Strong Buy

76

out of 100

Grade: B+

Growth: 7.3Profit: 7.0Value: 10.0Quality: 7.5
Piotroski: 6/9Altman Z: 2.97
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

Intrinsic value data unavailable for AIRS.

UHSUndervalued (+78.6%)

Margin of Safety

+78.6%

Fair Value

$1081.08

Current Price

$186.72

$894.36 discount

UndervaluedFair: $1081.08Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

AIRS1 strengths · Avg: 8.0/10
Price/BookValuation
2.3x8/10

Reasonable price relative to book value

UHS4 strengths · Avg: 8.8/10
P/E RatioValuation
8.1x10/10

Attractively priced relative to earnings

Return on EquityProfitability
21.3%9/10

Every $100 of equity generates 21 in profit

Price/BookValuation
1.6x8/10

Reasonable price relative to book value

EPS GrowthGrowth
42.7%8/10

Earnings expanding 42.7% YoY

Areas to Watch

AIRS4 concerns · Avg: 3.3/10
EPS GrowthGrowth
2.0%4/10

2.0% earnings growth

Market CapQuality
$165.46M3/10

Smaller company, higher risk/reward

Debt/EquityHealth
1.033/10

Elevated debt levels

Piotroski F-ScoreQuality
1/93/10

Weak financial health signals

UHS0 concerns · Avg: 0/10

No major concerns identified

Comparative Analysis Report

WallStSmart Research

Bull Case : AIRS

The strongest argument for AIRS centers on Price/Book.

Bull Case : UHS

The strongest argument for UHS centers on P/E Ratio, Return on Equity, Price/Book. PEG of 1.29 suggests the stock is reasonably priced for its growth.

Bear Case : AIRS

The primary concerns for AIRS are EPS Growth, Market Cap, Debt/Equity.

Bear Case : UHS

No major red flags identified for UHS, but monitor valuation.

Key Dynamics to Monitor

AIRS profiles as a turnaround stock while UHS is a value play — different risk/reward profiles.

AIRS carries more volatility with a beta of 2.80 — expect wider price swings.

UHS is growing revenue faster at 9.1% — sustainability is the question.

UHS generates stronger free cash flow (293M), providing more financial flexibility.

Bottom Line

UHS scores higher overall (76/100 vs 40/100). Both earn "Strong Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Airsculpt Technologies Inc

HEALTHCARE · MEDICAL CARE FACILITIES · USA

Airsculpt Technologies Inc (AIRS) is at the forefront of the aesthetic medical technology sector, renowned for its innovative AirSculpt® procedure, which provides minimally invasive body contouring solutions. The company prioritizes patient safety and comfort while delivering remarkable aesthetic outcomes, thereby transforming the cosmetic surgery experience. With a robust network of licensed practitioners and a strong commitment to technological advancement, Airsculpt is strategically positioned to capitalize on the increasing global demand for non-invasive cosmetic procedures, aiming to enhance its market presence and diversify its offerings. This proactive approach not only drives immediate growth but also sets the foundation for sustainable long-term value creation for its investors.

Visit Website →

Universal Health Services Inc

HEALTHCARE · MEDICAL CARE FACILITIES · USA

UnitedHealth Group Incorporated is an American for-profit multinational managed healthcare and insurance company based in Minnetonka, Minnesota. It offers health care products and insurance services.

Visit Website →

Want to dig deeper into these stocks?